Published in World J Gastroenterol on November 28, 2005
Severe acute pancreatitis: pathogenetic aspects and prognostic factors. World J Gastroenterol (2008) 1.51
Prognosis in acute pancreatitis. CMAJ (2011) 1.16
A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg (1993) 10.23
Acute pancreatitis. N Engl J Med (1994) 5.32
Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet (1974) 5.15
Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet (2000) 3.16
Prognostic factors in acute pancreatitis. Gut (1984) 2.94
Acute pancreatitis: prognostic value of CT. Radiology (1985) 2.79
Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg (1990) 2.36
Hemoconcentration: an early marker of severe and/or necrotizing pancreatitis? A critical appraisal. Am J Gastroenterol (2001) 2.28
Acute necrotizing pancreatitis. N Engl J Med (1999) 2.06
Hemoconcentration is an early marker for organ failure and necrotizing pancreatitis. Pancreas (2000) 1.97
A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet (1993) 1.91
Relationship of necrosis to organ failure in severe acute pancreatitis. Gastroenterology (1997) 1.83
Etiological and prognostic factors in human acute pancreatitis: a review. Am J Gastroenterol (1982) 1.79
A compaative study of methods for the prediction of severity of attacks of acute pancreatitis. Br J Surg (1980) 1.67
Blood concentrations of polymorphonuclear leucocyte elastase and interleukin-6 are indicators for the occurrence of multiple organ failures at the early stage of acute pancreatitis. J Gastroenterol Hepatol (1998) 1.63
Etiology and pathogenesis of acute pancreatitis: current concepts. J Clin Gastroenterol (2000) 1.45
Proinflammatory cytokines in early assessment of the prognosis of acute pancreatitis. Am J Gastroenterol (1999) 1.32
Controlled clinical trial of pefloxacin versus imipenem in severe acute pancreatitis. Gastroenterology (1998) 1.23
Obesity: a risk factor for severe acute biliary and alcoholic pancreatitis. Am J Gastroenterol (1998) 1.16
Hemoconcentration as an early risk factor for necrotizing pancreatitis. Am J Gastroenterol (1998) 1.13
Android fat distribution as predictor of severity in acute pancreatitis. Pancreatology (2002) 1.09
Role of cytokines and oxidative stress in the pathophysiology of acute pancreatitis: therapeutical implications. Curr Drug Targets Inflamm Allergy (2002) 1.07
Severe acute pancreatitis: prognostic factors in 270 consecutive patients. Pancreas (2000) 1.02
Isovolemic hemodilution with dextran 60 as treatment of pancreatic ischemia in acute pancreatitis. Clinical practicability of an experimental concept. Ann Surg (1993) 1.01
Effect of endothelin and endothelin receptor blockade on capillary permeability in experimental pancreatitis. Gut (2000) 0.95
Endothelin receptor blockade in severe acute pancreatitis leads to systemic enhancement of microcirculation, stabilization of capillary permeability, and improved survival rates. Surgery (2000) 0.92
Risk of death from acute pancreatitis. Role of early, simple "routine" data. Int J Pancreatol (1996) 0.92
Impairment of pancreatic microcirculation correlates with the severity of acute experimental pancreatitis. J Am Coll Surg (1994) 0.91
ACUTE PANCREATITIS. THE SIGNIFICANCE OF HEMOCONCENTRATION AT ADMISSION TO THE HOSPITAL. Arch Surg (1965) 0.87
Severe acute pancreatitis: when to be concerned? Pancreatology (2003) 0.86
Staging of acute pancreatitis. Is it important? Surg Clin North Am (1999) 0.85
Red cell indices in normal adults residing at altitude from sea level to 2670 meters. Am J Hematol (1980) 0.84
Urinary trypsinogen activation peptide is more accurate than hematocrit in determining severity in patients with acute pancreatitis: a prospective study. Am J Gastroenterol (2002) 0.82
Hematocrit determination (HCT) as an early marker associated with necrotizing pancreatitis and organ failure. Pancreas (2001) 0.77
Increased mortality among patients taking digoxin--analysis from the AFFIRM study. Eur Heart J (2012) 3.52
Electrocardiographic abnormalities in patients with acute pancreatitis. J Clin Gastroenterol (2005) 1.64
Is there an association between external cardioversions and long-term mortality and morbidity? Insights from the Atrial Fibrillation Follow-up Investigation of Rhythm Management study. Circ Arrhythm Electrophysiol (2011) 1.42
Systemic lupus erythematosus as a cause and prognostic factor of acute pancreatitis. J Rheumatol (2004) 1.22
Catheter ablation of atrial fibrillation without the use of fluoroscopy. Heart Rhythm (2010) 1.13
Android fat distribution as predictor of severity in acute pancreatitis. Pancreatology (2002) 1.09
Triggering receptor expressed on myeloid cells-1 expression on monocytes is associated with inflammation but not with infection in acute pancreatitis. Crit Care (2009) 1.03
Atrial fibrillation termination as a procedural endpoint during ablation in long-standing persistent atrial fibrillation. Heart Rhythm (2010) 1.00
Anabolic-androgenic steroids and liver injury. Liver Int (2007) 1.00
Th2-associated alternative Kupffer cell activation promotes liver fibrosis without inducing local inflammation. Int J Biol Sci (2011) 0.94
Frequency of functional bowel disorders among healthy volunteers in Mexico City. Dig Dis (2006) 0.93
Capsaicin consumption, Helicobacter pylori positivity and gastric cancer in Mexico. Int J Cancer (2003) 0.89
Lower serum IL-10 is an independent predictor of IBS among volunteers in Mexico. Am J Gastroenterol (2012) 0.86
Serum hyperviscosity syndrome responding to therapeutic plasmapheresis in a patient with primary Sjögren's syndrome. J Clin Apher (2002) 0.86
Hyperleptinemia is associated with parameters of low-grade systemic inflammation and metabolic dysfunction in obese human beings. Front Integr Neurosci (2013) 0.83
Expression and localization of endocrine gland-derived vascular endothelial growth factor (EG-VEGF) in human pancreas and pancreatic adenocarcinoma. J Steroid Biochem Mol Biol (2007) 0.83
[Steroid hormones and pancreas: a new paradigm]. Rev Invest Clin (2007) 0.81
Likelihood ratios of clinical, laboratory and image data of pancreatic cancer: Bayesian approach. J Eval Clin Pract (2009) 0.80
Time frames for analysis of inflammatory mediators in acute pancreatitis: improving admission triage. Dig Dis Sci (2008) 0.80
Is leptin related to systemic inflammatory response in acute pancreatitis? World J Gastroenterol (2006) 0.80
Cerebral haemodynamics in cirrhotic patients with hepatic encephalopathy. Liver Int (2014) 0.79
Emerging concepts in inflammation and fibrosis. Arch Med Res (2002) 0.79
Evidence of an intracellular angiotensin-generating system and non-AT1, non-AT2 binding site in a human pancreatic cell line. Pancreas (2011) 0.78
Intestinal involvement is not sufficient to explain hypertransaminasemia in celiac disease? Med Hypotheses (2005) 0.77
Expression of nerve growth factor in human pancreatic beta cells. Growth Factors (2004) 0.77
Bcl-2 overexpression in hepatic stellate cell line CFSC-2G, induces a pro-fibrotic state. J Gastroenterol Hepatol (2010) 0.76
Differential expression of steroidogenic factors 1 and 2, cytochrome p450scc, and steroidogenic acute regulatory protein in human pancreas. Pancreas (2008) 0.76
When should we be concerned about pancreatic necrosis? Analysis from a single institution in Mexico City. World J Surg (2006) 0.76
Liver exhibits thermal variations according to the stage of fibrosis progression: A novel use of modulated-differential scanning calorimetry for research in hepatology. Hepatol Res (2012) 0.75
Effective use of FibroTest to generate decision trees in hepatitis C. World J Gastroenterol (2009) 0.75
[Diabetes mellitus in acute pancreatitis]. Rev Gastroenterol Mex (2003) 0.75
Immunohistochemical expression of luteinizing hormone receptor in solid pseudopapillary tumor of the pancreas. Pancreas (2014) 0.75
[Endoscopic cholangiography in mild acute biliary pancreatitis: when and for whom?]. Rev Gastroenterol Mex (2002) 0.75
[Are they useful, prophylactic antibiotics in management of acute pancreatitis?]. Rev Gastroenterol Mex (2009) 0.75
[Pancreatic stellate cells and chronic pancreatitis]. Rev Gastroenterol Mex (2005) 0.75
Expression of steroidogenic factors 1 and 2 in normal human pancreas. J Steroid Biochem Mol Biol (2006) 0.75
[Obesity and its implication in gastroenterological diseases]. Rev Gastroenterol Mex (2006) 0.75
[Role of laparoscopy with ultrasound in the staging process of pancreatic and ampullary tumors]. Gac Med Mex (2003) 0.75
Chemical composition and antibacterial activity of the essential oil of Retrohpyllum rospigliosii fruits from Colombia. Nat Prod Commun (2010) 0.75
The beta form of the estrogen receptor is predominantly expressed in the papillary cystic neoplasm of the pancreas. Pancreas (2003) 0.75
[Effect of preoperative biliary drainage on surgical outcome after pancreatoduodenectomy]. Rev Invest Clin (2005) 0.75
[Clinical guidelines for the diagnosis and treatment of acute pancreatitis. Treatment]. Rev Gastroenterol Mex (2008) 0.75
Endoscopic treatment of high-risk bleeding ulcers: success, rebleeding and mortality. Rev Invest Clin (2008) 0.75
Balloon-facilitated delivery of a left ventricular pacing lead. Pacing Clin Electrophysiol (2011) 0.75
Extensive left atrial thrombus in a cocaine user with a bioprosthetic mitral valve, sinus rhythm, and left ventricular dysfunction. Echocardiography (2007) 0.75